Table 1.
Items | Controls (N = 320) | AIS patients (N = 320) | P value |
---|---|---|---|
Age (y), mean ± SD | 61.6 ± 9.1 | 62.6 ± 10.8 | .225 |
Gender, No. (%) | |||
Female | 65 (20.3) | 76 (23.8) | .294 |
Male | 255 (79.7) | 244 (76.3) | |
BMI (kg/m2), mean ± SD | 24.2 ± 2.8 | 24.7 ± 2.9 | .013 |
Current smoke, No. (%) | |||
No | 186 (58.1) | 179 (55.9) | .576 |
Yes | 134 (41.9) | 141 (44.1) | |
Common complications, No. (%) | |||
Hypertension | 239 (74.7) | 274 (85.6) | .001 |
Hyperlipidemia | 150 (46.9) | 156 (48.8) | .635 |
Hyperuricemia | 101 (31.6) | 107 (33.4) | .613 |
Diabetes mellitus | 60 (18.8) | 77 (24.1) | .101 |
CKD | 30 (9.4) | 51 (15.9) | .013 |
NIHSS score, mean ± SD | – | 8.4 ± 3.5 | – |
Biochemical indexes, median (IQR) | – | – | |
CRP (mg/L) | – | 41.5 (32.5‐57.2) | – |
TNF‐α (pg/mL) | – | 41.2 (29.5‐57.8) | – |
IL‐1β (pg/mL) | – | 89.8 (61.5‐148.4) | – |
IL‐6 (pg/mL) | – | 7.9 (4.9‐10.7) | – |
IL‐8 (pg/mL) | – | 71.0 (56.0‐93.1) | – |
IL‐17 (pg/mL) | – | 79.0 (56.2‐113.6) | – |
IL‐22 (pg/mL) | – | 148.9 (92.3‐201.7) | – |
Comparison was determined by Student's t test or the chi‐square test.
Abbreviations: AIS, acute ischemic stroke; BMI, body mass index; CKD, chronic kidney disease; CRP, C‐reactive protein; IL, interleukin; IQR, interquartile range; NIHSS, National Institute of Health stroke scale; SD, standard deviation; TNF‐α, tumor necrosis factor‐α.